Market Cap
$14.18M
Shares Outstanding
17.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 31, 2014
Round Lot
100
Locale
US
Day Open
$0.82
Day High
$0.85
Day Low
$0.64
Volume
700.8K
VWAP
$0.76
Prev Close
$0.81
Transactions
--
Acc. Volume
--
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Enlivex Ltd. Ordinary Shares (ENLV) closed the 2026-09-17 session at $0.70, down 13.27% versus the previous close (-0.11). The stock opened at $0.82 and traded between $0.64 and $0.85 during that session. Session trading volume was 701K shares. The volume-weighted average price (VWAP) is $0.76.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Enlivex Ltd. Ordinary Shares has a market capitalization of $14.2 million. ENLV is listed on the XNAS exchange. The company employs approximately 34 people. The recorded listing date is 2014-07-31.
On this page you can find market ENLV stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.